EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Identification of Potential Clovibactin-like Antibiotics Binding to Unique Cell Wall Precursors in Diverse Gram-Positive Bacterial Strains

Olimpo Sierra-Hernandez iD, Oscar Saurith-Coronell iD, Juan Rodríguez-Macías iD, Edgar Márquez iD, José Ramón Mora iD, José L Paz, Maryury Flores-Sumoza, Adel Mendoza-Mendoza, Virginia Flores-Morales iD, Yovani Marrero-Ponce, Stephen J Barigye, Felix Martinez-Rios

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26041724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Olimpo Sierra-Hernandez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Medicina, División Ciencias de la Salud, Universidad del Norte, Km 5, Vía Puerto Colombia, Puerto Colombia 081007, Colombia. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Cell Wall, Gram-Positive Bacteria, Uridine Diphosphate N-Acetylmuramic Acid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise in multidrug-resistant bacteria highlights the critical need for novel antibiotics. This study explores clovibactin-like compounds as potential therapeutic agents targeting lipid II, a crucial component in bacterial cell wall synthesis, using in silico techniques. A total of 2624 clovibactin analogs were sourced from the PubChem database and screened using ProTox 3.0 software based on their ADME-Tox properties, prioritizing candidates with favorable pharmacokinetic profiles and minimal toxicity. Molecular docking protocols were then employed to assess the binding interactions of the selected compounds with lipid II. Our analysis identified Compound 22 as a particularly promising candidate, exhibiting strong binding affinity, stable complex formation, and high selectivity for the target. Binding energy analysis, conducted via molecular dynamics simulations, revealed a highly negative value of −25.50 kcal/mol for Compound 22, surpassing that of clovibactin and underscoring its potential efficacy. In addition, Compound 22 was prioritized due to its exceptional binding affinity to lipid II and its favorable ADME-Tox properties, suggesting a lower likelihood of adverse effects. These characteristics position Compound 22 as a promising candidate for further pharmacological development. While our computational results are encouraging, experimental validation is essential to confirm the efficacy and safety of these compounds. This study not only advances our understanding of clovibactin analogs but also contributes to the ongoing efforts to combat antimicrobial resistance through innovative antibiotic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsCell WallGram-Positive BacteriaUridine Diphosphate N-Acetylmuramic AcidMolecular Docking SimulationMolecular Dynamics SimulationComputer Simulation

Stichwörter der Autor:innen

ADME-Toxbinding affinity propertiescell wall synthesisclovibactin analogsin silicoligand-receptor interactionslipid IImolecular dynamicssolvation energy

Substanzen

Anti-Bacterial AgentsUridine Diphosphate N-Acetylmuramic Acidmuramyl-NAc-(pentapeptide)pyrophosphoryl-undecaprenol

Autor:innen und Institutionen

  • Departamento de Medicina, División Ciencias de la Salud, Universidad del Norte, Km 5, Vía Puerto Colombia, Puerto Colombia 081007, Colombia.
  • Grupo de Investigaciones en Química y Biología, Departamento de Química y Biología, Facultad de Ciencias Básicas, Universidad del Norte, Carrera 51B, Km 5, Vía Puerto Colombia, Barranquilla 081007, Colombia.
  • Facultad de Ciencias de la Salud, Exactas y Naturales, Universidad Libre, Barranquilla 080001, Colombia.
  • Grupo de Química Computacional y Teórica (QCT-USFQ), Departamento de Ingeniería Química, Universidad San Francisco de Quito, Diego de Robles y Vía Interoceánica, Quito 170901, Ecuador.
  • Departamento Académico de Química Inorgánica, Facultad de Química e Ingeniería Química, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.
  • Programa de Química y Farmacia, Facultad de Ciencias Básicas y Biomédicas, Universidad Simón Bolívar, Carrera 59 N° 59-65, Barranquilla 080002, Colombia.

ORCID-Profile: Olimpo Sierra-Hernandez, Oscar Saurith-Coronell, Juan Rodríguez-Macías, Edgar Márquez, José Ramón Mora, Virginia Flores-Morales

Zitieren

APA

Sierra-Hernandez, O., Saurith-Coronell, O., Rodríguez-Macías, J., Márquez, E., Mora, J. R., Paz, J. L., Flores-Sumoza, M., Mendoza-Mendoza, A., Flores-Morales, V., Marrero-Ponce, Y., Barigye, S. J., & Martinez-Rios, F. (2025). In Silico Identification of Potential Clovibactin-like Antibiotics Binding to Unique Cell Wall Precursors in Diverse Gram-Positive Bacterial Strains. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041724

Vancouver

Sierra-Hernandez O, Saurith-Coronell O, Rodríguez-Macías J, Márquez E, Mora JR, Paz JL, et al. In Silico Identification of Potential Clovibactin-like Antibiotics Binding to Unique Cell Wall Precursors in Diverse Gram-Positive Bacterial Strains. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041724

BibTeX
@article{SierraHernandez2025,
  author = {Sierra-Hernandez, Olimpo and Saurith-Coronell, Oscar and Rodríguez-Macías, Juan and Márquez, Edgar and Mora, José Ramón and Paz, José L and Flores-Sumoza, Maryury and Mendoza-Mendoza, Adel and Flores-Morales, Virginia and Marrero-Ponce, Yovani and Barigye, Stephen J and Martinez-Rios, Felix},
  title = {In Silico Identification of Potential Clovibactin-like Antibiotics Binding to Unique Cell Wall Precursors in Diverse Gram-Positive Bacterial Strains},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26041724}
}
Kostenlos starten →